Entry |
|
Name |
Dopamine hydrochloride (JP18/USP); Actopamin (TN); Intropin (TN) |
Product |
|
Generic |
|
Formula |
C8H11NO2. HCl
|
Exact mass |
189.0557
|
Mol weight |
189.64
|
Structure |

|
Simcomp |
|
Class |
Cardiovascular agent
DG01703 Cardiotonic
DG01699 Catecholamine cardiotonic
Neuropsychiatric agent
DG01472 Dopamine agonist
Metabolizing enzyme substrate
DG01592 COMT substrate
DG02917 MAO substrate
DG03179 MAOB substrate
Transporter substrate
DG02854 SLC22A2 substrate
|
Remark |
Therapeutic category: | 2119 |
Product (DG00213): | D00633<JP/US> |
|
Efficacy |
Cardiotonic, Dopamine receptor agonist |
Disease |
Myocardial infarction [DS: H01730] |
Comment |
Catecholamine derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Metabolism |
Enzyme: MAOB [HSA: 4129], COMT [HSA: 1312]
Transporter: SLC22A2 [HSA: 6582]
|
Interaction |
|
Structure map |
map07213 | Dopamine receptor agonists/antagonists |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA04 Dopamine
D00633 Dopamine hydrochloride (JP18/USP) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
211 Cardiotonics
2119 Others
D00633 Dopamine hydrochloride (JP18/USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01699 Catecholamine cardiotonic
DG00213 Dopamine
D00633 Dopamine hydrochloride
Neuropsychiatric agent
DG01472 Dopamine agonist
DG00213 Dopamine
D00633 Dopamine hydrochloride
Metabolizing enzyme substrate
DG01592 COMT substrate
DG00213 Dopamine
D00633 Dopamine hydrochloride
DG02917 MAO substrate
DG03179 MAOB substrate
DG00213 Dopamine
D00633 Dopamine hydrochloride
Transporter substrate
DG02854 SLC22A2 substrate
DG00213 Dopamine
D00633 Dopamine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD
D00633 Dopamine hydrochloride (JP18/USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00633 Dopamine hydrochloride
D00633 Dopamine hydrochloride injection
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00633
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00633
Drug transporters
D00633
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01699 Catecholamine cardiotonic
DG00213 Dopamine
Neuropsychiatric agent
DG01472 Dopamine agonist
DG00213 Dopamine
Metabolizing enzyme substrate
DG01592 COMT substrate
DG00213 Dopamine
DG02917 MAO substrate
DG03179 MAOB substrate
DG00213 Dopamine
Transporter substrate
DG02854 SLC22A2 substrate
DG00213 Dopamine
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 12
1 C8y C 28.7000 -14.7000
2 C8x C 27.5100 -14.0000
3 C8x C 28.7000 -16.1000
4 C1b C 29.8900 -14.0000
5 C8y C 26.3200 -14.7000
6 C8x C 27.5100 -16.8000
7 C1b C 31.1500 -14.7000
8 C8y C 26.3200 -16.1000
9 O1a O 25.0600 -14.0000
10 N1a N 32.3400 -14.0000
11 O1a O 25.0600 -16.8000
12 X Cl 32.5500 -16.8000
BOND 11
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 5 8 1
8 5 9 1
9 7 10 1
10 8 11 1
11 6 8 2
|